Global Growth Companies With High Insider Ownership
As global markets navigate a landscape marked by interest rate hikes and fluctuating oil prices, growth stocks have shown resilience, particularly in technology sectors that continue to capture investor attention. In this environment, companies with high insider ownership can offer unique insights into potential growth opportunities, as insiders often have aligned interests with shareholders and confidence in the long-term prospects of their businesses.
Top 10 Growth Companies With High Insider Ownership Globally
| Name | Insider Ownership | Earnings Growth |
| Shanghai Biren Technology (SEHK:6082) | 10.4% | 119.7% |
| Pharma Mar (BME:PHM) | 12.1% | 39.8% |
| Meitu (SEHK:1357) | 22.9% | 30.7% |
| Meiko Electronics (TSE:6787) | 19.2% | 33.8% |
| KebNi (OM:KEBNI B) | 16.3% | 103.8% |
| Gpixel Changchun Microelectronics (SEHK:3277) | 18.2% | 31.9% |
| Gold Road International (OB:GOLDR) | 35.9% | 89.8% |
| CD Projekt Red (WSE:CDR) | 35.2% | 50.1% |
| Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) | 14.1% | 39.2% |
| Beijing Luzhu Biotechnology (SEHK:2480) | 39.7% | 84.3% |
Let's review some notable picks from our screened stocks.
APR (KOSE:A278470)
Simply Wall St Growth Rating: ★★★★★★
Overview: APR Co., Ltd. manufactures and sells cosmetic products for men and women, with a market cap of ₩13.53 billion.
Operations: The company's revenue primarily comes from its Cosmetics Division, contributing ₩2.97 billion, with additional income from the Clothing and Fashion Division amounting to ₩18.39 million.
Insider Ownership: 34.7%
APR Co., Ltd. is experiencing significant growth, with its revenue expected to increase by 30.2% annually, outpacing the Korean market's 14.5% forecast. The company's earnings are projected to grow by 32.3% per year, surpassing market expectations of 28.2%. Recent initiatives like the Medicube pop-up tour in major U.S. and European cities aim to capitalize on strong international demand and further enhance APR's global footprint in advanced beauty technology markets.
- Dive into the specifics of APR here with our thorough growth forecast report.
- Upon reviewing our latest valuation report, APR's share price might be too pessimistic.
Shanghai OPM Biosciences (SHSE:688293)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Shanghai OPM Biosciences Co., Ltd. operates in the biotechnology sector, offering cell culture media and CDMO services both in China and internationally, with a market cap of CN¥10.72 billion.
Operations: Shanghai OPM Biosciences Co., Ltd. generates revenue through its provision of cell culture media and contract development and manufacturing organization (CDMO) services across domestic and international markets.
Insider Ownership: 20%
Shanghai OPM Biosciences is experiencing rapid growth, with earnings projected to increase significantly over the next three years. Despite high volatility in its share price recently, the company's revenue is expected to grow by 22.9% annually, outpacing the Chinese market's 17.5% forecast. Recent financial results show substantial year-over-year increases in sales and net income for H1 2026, although past shareholder dilution remains a concern.
- Take a closer look at Shanghai OPM Biosciences' potential here in our earnings growth report.
- According our valuation report, there's an indication that Shanghai OPM Biosciences' share price might be on the expensive side.
Kehua Data (SZSE:002335)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Kehua Data Co., Ltd. offers integrated solutions for power protection and energy conservation both in China and internationally, with a market cap of CN¥22.83 billion.
Operations: The company's revenue is primarily derived from its New Energy Industry Division at CN¥3.90 billion, followed by the Data Center Industry Division at CN¥3.73 billion, and the Smart Power Industry Division contributing CN¥883.99 million.
Insider Ownership: 17.4%
Kehua Data anticipates significant earnings growth of 29.23% annually over the next three years, surpassing the Chinese market's average. Despite a Price-To-Earnings ratio of 43.1x, which is lower than the industry average, its Return on Equity is forecasted to be modest at 15.3%. Recent financials show strong year-over-year revenue and net income increases for H1 2026. The company recently amended its articles of association and business scope following an extraordinary general meeting in September 2026.
- Delve into the full analysis future growth report here for a deeper understanding of Kehua Data.
- Insights from our recent valuation report point to the potential overvaluation of Kehua Data shares in the market.
Next Steps
- Embark on your investment journey to our 723 Fast Growing Global Companies With High Insider Ownership selection here.
- Want To Explore Some Alternatives? We've found 7 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com